Syndax Pharmaceuticals Statistics
Total Valuation
SNDX has a market cap or net worth of $2.09 billion. The enterprise value is $2.02 billion.
Important Dates
The next estimated earnings date is Monday, May 4, 2026, after market close.
| Earnings Date | May 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SNDX has 88.20 million shares outstanding. The number of shares has increased by 1.17% in one year.
| Current Share Class | 88.20M |
| Shares Outstanding | 88.20M |
| Shares Change (YoY) | +1.17% |
| Shares Change (QoQ) | +0.85% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 98.94% |
| Float | 74.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.10 |
| Forward PS | 5.65 |
| PB Ratio | 31.98 |
| P/TBV Ratio | 32.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.40, with a Debt / Equity ratio of 5.34.
| Current Ratio | 4.40 |
| Quick Ratio | 4.03 |
| Debt / Equity | 5.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.09 |
Financial Efficiency
Return on equity (ROE) is -161.82% and return on invested capital (ROIC) is -32.75%.
| Return on Equity (ROE) | -161.82% |
| Return on Assets (ROA) | -27.25% |
| Return on Invested Capital (ROIC) | -32.75% |
| Return on Capital Employed (ROCE) | -66.77% |
| Weighted Average Cost of Capital (WACC) | 6.89% |
| Revenue Per Employee | $578,362 |
| Profits Per Employee | -$957,792 |
| Employee Count | 298 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 12.84 |
Taxes
| Income Tax | -400,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +81.37% in the last 52 weeks. The beta is 0.46, so SNDX's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +81.37% |
| 50-Day Moving Average | 21.39 |
| 200-Day Moving Average | 16.34 |
| Relative Strength Index (RSI) | 61.35 |
| Average Volume (20 Days) | 1,386,972 |
Short Selling Information
The latest short interest is 21.80 million, so 24.71% of the outstanding shares have been sold short.
| Short Interest | 21.80M |
| Short Previous Month | 22.12M |
| Short % of Shares Out | 24.71% |
| Short % of Float | 29.19% |
| Short Ratio (days to cover) | 18.12 |
Income Statement
In the last 12 months, SNDX had revenue of $172.35 million and -$285.42 million in losses. Loss per share was -$3.29.
| Revenue | 172.35M |
| Gross Profit | -93.40M |
| Operating Income | -273.48M |
| Pretax Income | -285.82M |
| Net Income | -285.42M |
| EBITDA | -273.48M |
| EBIT | -273.48M |
| Loss Per Share | -$3.29 |
Full Income StatementBalance Sheet
The company has $413.69 million in cash and $345.43 million in debt, with a net cash position of $68.25 million or $0.77 per share.
| Cash & Cash Equivalents | 413.69M |
| Total Debt | 345.43M |
| Net Cash | 68.25M |
| Net Cash Per Share | $0.77 |
| Equity (Book Value) | 64.63M |
| Book Value Per Share | 0.74 |
| Working Capital | 407.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$322.98 million and capital expenditures -$187,000, giving a free cash flow of -$323.17 million.
| Operating Cash Flow | -322.98M |
| Capital Expenditures | -187,000 |
| Free Cash Flow | -323.17M |
| FCF Per Share | -$3.66 |
Full Cash Flow StatementMargins
Gross margin is -54.19%, with operating and profit margins of -158.68% and -165.60%.
| Gross Margin | -54.19% |
| Operating Margin | -158.68% |
| Pretax Margin | -165.84% |
| Profit Margin | -165.60% |
| EBITDA Margin | -158.67% |
| EBIT Margin | -158.68% |
| FCF Margin | n/a |
Dividends & Yields
SNDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.17% |
| Shareholder Yield | -1.17% |
| Earnings Yield | -13.68% |
| FCF Yield | -15.49% |
Analyst Forecast
The average price target for SNDX is $84.17, which is 255.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $84.17 |
| Price Target Difference | 255.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 45.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNDX has an Altman Z-Score of -2.89 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.89 |
| Piotroski F-Score | 2 |
